Literature DB >> 16671028

Cluster of cases of severe acute respiratory syndrome among Toronto healthcare workers after implementation of infection control precautions: a case series.

Marianna Ofner-Agostini1, Denise Gravel, L Clifford McDonald, Marcus Lem, Shelley Sarwal, Allison McGeer, Karen Green, Mary Vearncombe, Virginia Roth, Shirley Paton, Mark Loeb, Andrew Simor.   

Abstract

OBJECTIVE: To review the severe acute respiratory syndrome (SARS) infection control practices, the types of exposure to patients with SARS, and the activities associated with treatment of such patients among healthcare workers (HCWs) who developed SARS in Toronto, Canada, after SARS-specific infection control precautions had been implemented.
METHODS: A retrospective review of work logs and patient assignments, detailed review of medical records of patients with SARS, and comprehensive telephone-based interviews of HCWs who met the case definition for SARS after implementation of infection control precautions.
RESULTS: Seventeen HCWs from 6 hospitals developed disease that met the case definition for SARS after implementation of infection control precautions. These HCWs had a mean age (+/-SD) of 39+/-2.3 years. Two HCWs were not interviewed because of illness. Of the remaining 15, only 9 (60%) reported that they had received formal infection control training. Thirteen HCWs (87%) were unsure of proper order in which personal protective equipment should be donned and doffed. Six HCWs (40%) reused items (eg, stethoscopes, goggles, and cleaning equipment) elsewhere on the ward after initial use in a room in which a patient with SARS was staying. Use of masks, gowns, gloves, and eyewear was inconsistent among HCWs. Eight (54%) reported that they were aware of a breach in infection control precautions. HCWs reported fatigue due to an increased number and length of shifts; participants worked a median of 10 shifts during the 10 days before onset of symptoms. Seven HCWs were involved in the intubation of a patient with SARS. One HCW died, and the remaining 16 recovered.
CONCLUSION: Multiple factors were likely responsible for SARS in these HCWs, including the performance of high-risk patient care procedures, inconsistent use of personal protective equipment, fatigue, and lack of adequate infection control training.

Entities:  

Mesh:

Year:  2006        PMID: 16671028     DOI: 10.1086/504363

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  37 in total

1.  Personal protective equipment for preventing respiratory infections: what have we really learned?

Authors:  John M Conly
Journal:  CMAJ       Date:  2006-08-01       Impact factor: 8.262

2.  Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, Canada.

Authors:  Janet Raboud; Altynay Shigayeva; Allison McGeer; Erika Bontovics; Martin Chapman; Denise Gravel; Bonnie Henry; Stephen Lapinsky; Mark Loeb; L Clifford McDonald; Marianna Ofner; Shirley Paton; Donna Reynolds; Damon Scales; Sandy Shen; Andrew Simor; Thomas Stewart; Mary Vearncombe; Dick Zoutman; Karen Green
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

3.  Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.

Authors:  Jos H Verbeek; Blair Rajamaki; Sharea Ijaz; Christina Tikka; Jani H Ruotsalainen; Michael B Edmond; Riitta Sauni; F Selcen Kilinc Balci
Journal:  Cochrane Database Syst Rev       Date:  2019-07-01

4.  Enhancing the triage and cohort of patients in public primary care clinics in response to the coronavirus disease 2019 (COVID-19) in Hong Kong: an experience from a hospital cluster.

Authors:  Pang Fai Chan; Kit Ping Loretta Lai; David Vai Kiong Chao; Sau Chun Kitty Fung
Journal:  BJGP Open       Date:  2020-06-23

Review 5.  Risk of SARS-CoV-2 transmission by aerosols, the rational use of masks, and protection of healthcare workers from COVID-19.

Authors:  Rami Sommerstein; Christoph Andreas Fux; Danielle Vuichard-Gysin; Mohamed Abbas; Jonas Marschall; Carlo Balmelli; Nicolas Troillet; Stephan Harbarth; Matthias Schlegel; Andreas Widmer
Journal:  Antimicrob Resist Infect Control       Date:  2020-07-06       Impact factor: 4.887

6.  Prevalence of Fatigue and Its Association With Quality of Life Among Frontline Clinicians in Ophthalmology and Otolaryngology Departments During the COVID-19 Pandemic.

Authors:  Yu Jin; Yue Li; Xiu-Ya Li; Yan-Jie Zhao; Teris Cheung; Gabor S Ungvari; Michael Li; Feng-Rong An; Yu-Tao Xiang
Journal:  Front Psychiatry       Date:  2021-07-09       Impact factor: 4.157

7.  Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.

Authors:  Jos H Verbeek; Blair Rajamaki; Sharea Ijaz; Riitta Sauni; Elaine Toomey; Bronagh Blackwood; Christina Tikka; Jani H Ruotsalainen; F Selcen Kilinc Balci
Journal:  Cochrane Database Syst Rev       Date:  2020-04-15

Review 8.  The emergence of the Middle East respiratory syndrome coronavirus.

Authors:  Shauna Milne-Price; Kerri L Miazgowicz; Vincent J Munster
Journal:  Pathog Dis       Date:  2014-04-09       Impact factor: 3.166

9.  Comparison of confirmed COVID-19 with SARS and MERS cases - Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis.

Authors:  Ali Pormohammad; Saied Ghorbani; Alireza Khatami; Rana Farzi; Behzad Baradaran; Diana L Turner; Raymond J Turner; Nathan C Bahr; Juan-Pablo Idrovo
Journal:  Rev Med Virol       Date:  2020-06-05       Impact factor: 11.043

Review 10.  Society for Advanced Bronchoscopy Consensus Statement and Guidelines for bronchoscopy and airway management amid the COVID-19 pandemic.

Authors:  Michael A Pritchett; Catherine L Oberg; Adam Belanger; Jose De Cardenas; George Cheng; Gustavo Cumbo Nacheli; Carlos Franco-Paredes; Jaspal Singh; Jennifer Toth; Michael Zgoda; Erik Folch
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.